THE Therapeutic Goods Administration has advised the manufacturing issue that resulted in limited availability of Neo-Mercazole (carbimazole) 5mg tablets (PD 30 Jan) has been resolved, with the unapproved products available as alternatives due to the shortage no longer available under section 19A.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Aug 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Aug 17
